Renal Denervation Insights

Published: 12 February 2021

  • Views:

    Views Icon 28450

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Global Experts Discuss Renal Denervation as an Additional Treatment Option for Uncontrolled Hypertension

Review the evidence on radiofrequency renal denervation, including safety, efficacy and durability data and practical aspects around patient selection and management.

 

 

Medical Education Program

Patient Selection and Practical Implementation of Renal Denervation in Patients With Treatment-Resistant Hypertension

This case-based course brings together opinion leaders engaged in RDN to review the evidence, discuss trial data, and practical aspects around patient selection and management. 

 

Click here to watch:

IME series

CME education

This educational content is supported by Medtronic.

More from this programme

Part 1

Clinical Data and Patient Identification

Global leaders share their expertise in the field of Renal Denervation. Key topics include latest RDN clinical evidence including Pivotal trial results, how to identify potential RDN patients, and the role of patient preference in hypertension management. Presented in English, Spanish, Italian, and German.
7 sessions
The Future of Hypertension Management – Renal Denervation Provides Another Treatment Option Watch now
El futuro del manejo de la hipertensión: la denervación renal brinda otra opción de tratamiento Watch now
Die Zukunft des Hypertoniemanagements – Renale Denervierung bietet eine weitere Behandlungsoption Watch now
Il futuro della gestione dell’ ipertensione - La Denervazione renale, una nuova opzione di trattamento Watch now
Clinical Event Reductions in High-Risk Hypertension Patients Treated with Radiofrequency Renal Denervation Watch now
Radiofrequency Renal Denervation in a High-risk Population: The Verona experience Watch now
Patient Profiles for Renal Denervation Watch now

Part 2

Science of Radiofrequency Renal Denervation

Experts explain the mechanism of action behind radiofrequency renal denervation, including evidence demonstrating long-term safety and efficacy.
3 sessions
The Science of Radiofrequency Renal Denervation – Part 1 Watch now
The Science of Radiofrequency Renal Denervation – Part 2 Watch now
TCT 2019: RF renal denervation – Prof Andrew Sharp Watch now

Faculty Biographies

Andrew SP Sharp

Andrew SP Sharp

Consultant Cardiologist

Prof Andrew Sharp is a Consultant Cardiologist at the University Hospital of Wales, Cardiff, UK. Andrew qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011 and Honorary Associate Professor by the University of Exeter in 2018 before moving to the University Hospital of Wales in Cardiff in the summer of 2019.

Andrew conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training, completing the prestigious Milan-Imperial Interventional Cardiology Fellowship programme. Dr Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his current research interests include device-based treatments for hypertension, pulmonary embolism, intracoronary imaging and coronary physiology.

Andrew's specialist interests include the pharmacological and interventional…

View full profile
Stefan Tunev

Stefan Tunev

Veterinary Pathologist, Fellow in Comparative Medicine, specializing in the field of medical device pathology

View full profile